Mercy Hospital & Health Services Contact Us
MyChart
About Mercy
Join Our Team
set font size large set font size medium set font size small
email this page print this page
Health Article Banner
Women's Health

Mercy Women's Care at St. Anne
3404 W. Sylvania Avenue
Toledo, OH 43623
419-407-1616

Mercy Women's Care at St. Charles
Navarre Medical Plaza
2702 Navarre Avenue
Suite 101
Oregon, OH 43616
696-7900

Mercy Women's Care at St. V's
2213 Cherry Street
Toledo, OH 43608
419-251-4340

New Drug for Multiple Myeloma

separator There’s a new drug treatment available for people who have multiple myeloma, which is a cancer of the bone marrow that’s often fatal. The new drug, marketed as Velcade, has been approved by the Food and Drug Administration for patients who have had relapses of their cancer after two other treatments.

There are about 50,000 Americans who have multiple myeloma. The survival rate used to be three years, but that’s changed in recent years as new drugs have become available. Thalidomide, which also is used to treat multiple myeloma, can cause remissions and tumor shrinkage in about one third of patients with this cancer.

In a clinical trial of Velcade, 28 percent of patients experienced tumor shrinkage and in 3 percent of patients, the cancer disappeared completely.

Source:
The New York Times, 14 May 2003



www.mercyweb.org
follow us online
facebook youtube


Contact us
Home  |  Sitemap

Disclaimer & Terms of Use  |  Privacy Statement  |  Notice of Privacy Practices
Copyright ©2013 Mercy. Last modified 9/27/2010